A Randomized Trial Comparing Defined-Duration With Continuous Irinotecan Until Disease Progression in Fluoropyrimidine and Thymidylate Synthase Inhibitor—Resistant Advanced Colorectal Cancer.
Journal of Clinical Oncology
Vol 22, No 15 (August 1), 2004: pp. 3023-3031
Rohit Lal, James Dickson, David Cunningham, Ian Chau, Andrew R. Norman, Paul J. Ross, Clare Topham, Gary Middleton, Mark Hill, Jacqui Oates
DOI: 10.1200/JCO.2004.01.005
Go to journal article.
Journal Article: Treatment Options for Advanced Colorectal CancerCancer Research - August 2004
From Donna Myers, former About.com Guide
Updated: August 6, 2005
About.com Health's Disease and Condition content is reviewed by the Medical Review Board
Explore Colon Cancer
Must Reads
About.com Special Features
8 Ways to Cut Drug Costs
Learn how to save money on medications with these recommendations. More >
Healthy Bodies, Healthy Minds
Keep yourself, and your family, happy and healthy this season. More >
Also from About.com:
©2010 About.com, a part of The New York Times Company.
All rights reserved.